These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1977037)

  • 1. Infection of human T cells with mycoplasma, inhibition of CD4 expression and HIV-1 gp120 glycoprotein binding, and infectivity.
    O'Toole C; Lowdell M
    Lancet; 1990 Oct; 336(8722):1067. PubMed ID: 1977037
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1].
    Mizuochi T
    Nihon Rinsho; 1992 Jun; 50(6):1419-29. PubMed ID: 1518160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
    Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in AIDS.
    Gougeon ML; Montagnier L
    Science; 1993 May; 260(5112):1269-70. PubMed ID: 8098552
    [No Abstract]   [Full Text] [Related]  

  • 7. A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera.
    Ghetie V; Wheeler T; Scott D; Uhr JW; Vitetta ES
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1945-8. PubMed ID: 1489581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection: the cellular picture.
    Weber JN; Weiss RA
    Sci Am; 1988 Oct; 259(4):100-9. PubMed ID: 2854299
    [No Abstract]   [Full Text] [Related]  

  • 9. Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120.
    Oravecz T; Norcross MA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):945-55. PubMed ID: 7506554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.
    Oyaizu N; Chirmule N; Kalyanaraman VS; Hall WW; Pahwa R; Shuster M; Pahwa S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2379-83. PubMed ID: 2315327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological bases of resistance to HIV/AIDS (the hypothesis with elements of the theory).
    Skripal IG
    Mikrobiol Z; 1995; 57(4):89-105. PubMed ID: 8548075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
    Yahi N; Fantini J; Baghdiguian S; Mabrouk K; Tamalet C; Rochat H; Van Rietschoten J; Sabatier JM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4867-71. PubMed ID: 7761414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.
    Banda NK; Bernier J; Kurahara DK; Kurrle R; Haigwood N; Sekaly RP; Finkel TH
    J Exp Med; 1992 Oct; 176(4):1099-106. PubMed ID: 1402655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.
    Kannagi M; Masuda T; Hattori T; Kanoh T; Nasu K; Yamamoto N; Harada S
    J Virol; 1990 Jul; 64(7):3399-406. PubMed ID: 1693704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
    Cohen S; Tuen M; Hioe CE
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for the T4 lymphopenia of AIDS.
    Micali S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10982-3. PubMed ID: 7902577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.